Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Autor:	Rischin, Danny Harrington, Kevin J. Greil, Richard and Soulieres, Denis Tahara, Makoto de Castro, Gilberto Psyrri, Amanda Baste, Neus Neupane, Prakash C. Bratland, Ase and Fuereder, Thorsten Hughes, Brett Gordon Maxwell Mesia, Ricard and Ngamphaiboon, Nuttapong Rordorf, Tamara Ishak, Wan Zamaniah Wan Zhang, Yayan Jin, Fan Gumuscu, Burak Burtness, Barbara
Jazyk:	angličtina
Rok vydání:	2019
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______2127::1147fb8722ab1dafa1adf5da9783badb https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3183947 Zobrazit plný text záznamu